The Sinonasal Tract: Another Potential "Hot Spot" for Carcinomas with Transcriptionally-Active Human Papillomavirus

Head and Neck Pathology

Volumn 8, Issue 3, 2014, Pages 241-249

  Lewis, James S ^a   Westra, William H ^b   Thompson, Lester D R ^c   Barnes, Leon ^d   Cardesa, Antonio ^e   Hunt, Jennifer L ^f   Williams, Michelle D ^g   Slootweg, Pieter J ^h   Triantafyllou, Asterios ⁱ   Woolgar, Julia A ⁱ   Devaney, Kenneth O ^j   Rinaldo, Alessandra ^k   Ferlito, Alfio ^k  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c WOODLAND HILLS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF BARCELONA   (Spain)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY OF LIVERPOOL   (United Kingdom)

^j Allegiance Health   (United States)

^k UNIVERSITY OF UDINE   (Italy)

more..

Author keywords

Human papillomavirus; Nonkeratinizing; p16; Sinonasal; Squamous cell carcinoma

Indexed keywords

COMPLICATION; HUMAN; PAPILLOMAVIRUS INFECTION; PARANASAL SINUS TUMOR; SQUAMOUS CELL CARCINOMA; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; HUMANS; PAPILLOMAVIRUS INFECTIONS; PARANASAL SINUS NEOPLASMS;

EID: 84905731675     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-013-0514-4     Document Type: Review

References (48)

1. Adelstein DJ, Ridge JA, Gillison ML, et al. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, DC. Head Neck. 2009;31(11): 1393-422.
2. Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005;32(Suppl 1): S59-66.
3. Chung CH, Gillison ML. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res. 2009;15(22): 6758-62.
4. Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010;116(9): 2166-73.
5. Jordan RC, Lingen MW, Perez-Ordonez B, et al. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol. 2012;36(7): 945-54.
6. Gao G, Chernock RD, Gay HA, et al. A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis. Int J Cancer. 2013;132(4): 882-90.
7. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1): 24-35.
8. Stelow EB, Jo VY, Stoler MH, et al. Human papillomavirus-associated squamous cell carcinoma of the upper aerodigestive tract. Am J Surg Pathol. 2010;34(7): e15-24.
9. Chernock RD, El-Mofty SK, Thorstad WL, Parvin CA, Lewis JS Jr. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol. 2009;3(3): 186-94.
10. Lewis JS Jr, Thorstad WL, Chernock RD, et al. p16 positive oropharyngeal squamous cell carcinoma: an entity with a favorable prognosis regardless of tumor HPV status. Am J Surg Pathol. 2010;34(8): 1088-96.
11. Weinberger PM, Yu Z, Haffty BG, et al. Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin Cancer Res. 2004;10(17): 5684-91.
12. Ukpo OC, Flanagan JJ, Ma XJ, et al. High risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol. 2011;35(9): 1343-50.
13. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100(6): 407-20.
14. Lechner M, Frampton GM, Fenton T, et al. Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV + and HPV- tumors. Genome Med. 2013;5(5): 49.
15. Dayyani F, Etzel CJ, Liu M, et al. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol. 2010;2: 15.
16. Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100(4): 261-9.
17. Dogan S, Hedberg ML, Ferris RL et al. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population. Head Neck. 2013 (e-pub ahead of print).
18. Robinson M, Suh YE, Paleri V, et al. Oncogenic human papillomavirus-associated nasopharyngeal carcinoma: an observational study of correlation with ethnicity, histological subtype and outcome in a UK population. Infect Agent Cancer. 2013;8(1): 30.
19. Singhi AD, Califano J, Westra WH. High-risk human papillomavirus in nasopharyngeal carcinoma. Head Neck. 2011;34(2): 213-8.
20. Alos L, Moyano S, Nadal A, et al. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer. 2009;115(12): 2701-9.
21. Bishop JA, Guo TW, Smith DF, et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol. 2013;37(2): 185-92.
22. Osguthorpe JD. Sinus neoplasia. Arch Otolaryngol Head Neck Surg. 1994;120(1): 19-25.
23. Muir C, Weiland L. Upper aerodigestive tract cancers. Cancer. 1995;75(1 Suppl): 147-53.
24. Robin PE, Powell DJ, Stansbie JM. Carcinoma of the nasal cavity and paranasal sinuses: incidence and presentation of different histological types. Clin Otolaryngol Allied Sci. 1979;4(6): 431-56.
25. Ansa B, Goodman M, Ward K, et al. Paranasal sinus squamous cell carcinoma incidence and survival based on surveillance, epidemiology, and end results data, 1973-2009. Cancer. 2013;119(14): 2602-10.
26. Barnes L. Schneiderian papillomas and nonsalivary glandular neoplasms of the head and neck. Mod Pathol. 2002;15(3): 279-97.
27. Kapadia SB, Barnes L, Pelzman K, et al. Carcinoma ex oncocytic schneiderian (cylindrical cell) papilloma. Am J Otolaryngol. 1993;14(5): 332-8.
28. Lawson W, Schlecht NF, Brandwein-Gensler M. The role of the human papillomavirus in the pathogenesis of schneiderian inverted papillomas: an analytic overview of the evidence. Head Neck Pathol. 2008;2(2): 49-59.
29. Schwerer MJ, Sailer A, Kraft K, et al. Expression of retinoblastoma gene product in respiratory epithelium and sinonasal neoplasms: relationship with p16 and cyclin D1 expression. Histol Histopathol. 2003;18(1): 143-51.
30. Syrjanen K, Syrjanen S. Detection of human papillomavirus in sinonasal papillomas: systematic review and meta-analysis. Laryngoscope. 2013;123(1): 181-92.
31. Kim SG, Lee OY, Choi JW, et al. Pattern of expression of cell cycle-related proteins in malignant transformation of sinonasal inverted papilloma. Am J Rhinol Allergy. 2011;25(2): 75-81.
32. Altavilla G, Staffieri A, Busatto G, et al. Expression of p53, p16INK4A, pRb, p21WAF1/CIP1, p27KIP1, cyclin D1, Ki-67 and HPV DNA in sinonasal endophytic Schneiderian (inverted) papilloma. Acta Otolaryngol. 2009;129(11): 1242-9.
33. Shah AA, Evans MF, Adamson CS, et al. HPV DNA is associated with a subset of Schneiderian papillomas but does not correlate with p16(INK4a) immunoreactivity. Head Neck Pathol. 2010;4(2): 106-12.
34. Syrjanen K, Syrjanen S. Detection of human papillomavirus in sinonasal carcinoma: systematic review and meta-analysis. Hum Pathol. 2013;44(6): 983-91.
35. El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2005;29(10): 1367-72.
36. Ringertz N. Pathology of malignant tumours arising in the nasal and paranasal cavities and maxilla. Acta Otolaryngol. 1938;27: 1-405.
37. Shanmugaratnam K. Nasal cavity and paranasal sinuses. In: Shanmugaratnam K, Sobin LH, editors. Histological typing of tumours of the upper respiratory tract. 2nd ed. Heidelberg, Germany: Springer; 1991. p. 3-6.
38. Pilch BZ, Bouquot JE, Thompson LDR. Squamous cell carcinoma. In: Barnes EL, Eveson JW, Reichart P, Sidranksy D, editors. World Health Organization pathology and genetics of head and neck tumours. Lyon, France: IARC Press; 2005. p. 15-7.
39. Takahashi Y, Bell D, Agarwal G et al. Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma. Head Neck. 2013 (e-pub ahead of print).
40. Jo VY, Mills SE, Stoler MH, et al. Papillary squamous cell carcinoma of the head and neck: frequent association with human papillomavirus infection and invasive carcinoma. Am J Surg Pathol. 2009;33(11): 1720-4.
41. Masand RP, El-Mofty SK, Ma XJ, et al. Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature. Head Neck Pathol. 2011;5(2): 108-16.
42. Begum S, Westra WH. Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol. 2008;32(7): 1044-50.
43. Wadsworth B, Bumpous JM, Martin AW, et al. Expression of p16 in sinonasal undifferentiated carcinoma (SNUC) without associated human papillomavirus (HPV). Head Neck Pathol. 2012;5(4): 349-54.
44. Boland JM, McPhail ED, Garcia JJ, et al. Detection of human papilloma virus and p16 expression in high-grade adenoid cystic carcinoma of the head and neck. Mod Pathol. 2012;25(4): 529-36.
45. Isayeva T, Said-Al-Naief N, Ren Z, et al. Salivary mucoepidermoid carcinoma: demonstration of transcriptionally active human papillomavirus 16/18. Head Neck Pathol. 2013;7(2): 135-48.
46. Bishop JA, Ogawa T, Stelow EB, et al. Human papillomavirus-related carcinoma with adenoid cystic-like features: a peculiar variant of head and neck cancer restricted to the sinonasal tract. Am J Surg Pathol. 2013;37(6): 836-44.
47. Thompson LD, Penner C, Ho NJ et al. Sinonasal tract and nasopharyngeal adenoid cystic carcinoma: a clinicopathologic and immunophenotypic study of 86 cases. Head Neck Pathol. 2013 (e-pub ahead of print).
48. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32): 4294-301.